Product Code: 978-1-68038-477-2
ENT Devices Market Growth & Trends:
The global ENT devices market size is expected to reach USD 37.72 billion by 2030, registering a CAGR of 5.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market's growth.
The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s & above, and more than 70% of people were in the 70s & above.
Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.
ENT Devices Market Report Highlights:
- The hearing aids segment dominated the market in 2024 and accounted for the largest revenue share of 31.06% and is also anticipated to register the fastest growth rate over the forecast period.
- The surgical ENT devices segment is anticipated to register a considerable growth rate over the forecast period.
- North America dominated the ENT devices industry in 2024 and accounted for the largest revenue share of 34.99%. Key factors contributing to growth of this region are growing geriatric population and increasing prevalence of hearing loss.
- The ENT devices market in the U.S. held the largest share of 90.35% in 2024 due to technological advancements and recent approvals received for several hearing devices.
- Asia Pacific is anticipated to be the significantly growing region in the market.Technological innovations, such as real-time monitoring, wireless technology, increase in healthcare spending in the Asia Pacific region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis
- 1.6.1.1. Segment Level Company Revenue Estimates
- 1.6.2. Top Down Market Estimation
- 1.6.2.1. Region & Country Based Segment Share Calculation
- 1.6.2.2. Multivariate Analysis
- 1.6.2.3. ENT Devices Market: CAGR Calculation
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. ENT Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. High prevalence of hearing loss
- 3.2.1.2. Growing geriatric population
- 3.2.1.3. Increasing penetration of minimally invasive ENT procedures
- 3.2.1.4. Technological advancements in ENT devices
- 3.2.2. Market restraint analysis
- 3.2.2.1. Risk associated with ENT surgery procedures
- 3.2.2.2. Shortage of ENT specialists
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
Chapter 4. ENT Devices Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1. ENT Devices Market: Product Movement Analysis and Market Share
- 4.2. ENT Devices Market: Product Segment Dashboard
- 4.3. Diagnostic ENT Devices
- 4.3.1. Diagnostic ENT devices market, 2018 - 2030 (USD Million)
- 4.3.2. Rigid endoscopes
- 4.3.2.1. Rigid endoscopes market, 2018 - 2030 (USD Million)
- 4.3.2.2. Sinuscopes
- 4.3.2.2.1. Sinuscopes market, 2018 - 2030 (USD Million)
- 4.3.2.3. Otoscopes
- 4.3.2.3.1. Otoscopes market, 2018 - 2030 (USD Million)
- 4.3.2.4. Laryngoscopes
- 4.3.2.4.1. Laryngoscopes market, 2018 - 2030 (USD Million)
- 4.3.3. Flexible endoscopes
- 4.3.3.1. Flexible endoscopes market, 2018 - 2030 (USD Million)
- 4.3.3.2. Bronchoscopes
- 4.3.3.2.1. Bronchoscopes market, 2018 - 2030 (USD Million)
- 4.3.3.3. Laryngoscopes
- 4.3.3.3.1. Laryngoscopes market, 2018 - 2030 (USD Million)
- 4.3.3.4. Nasopharyngoscopes
- 4.3.3.4.1. Nasopharyngoscopes market, 2018 - 2030 (USD Million)
- 4.3.4. Robot assisted endoscope
- 4.3.4.1. Robot assisted endoscope market, 2018 - 2030 (USD Million)
- 4.3.5. Hearing screening device
- 4.3.5.1. Hearing screening devicemarket, 2018 - 2030 (USD Million)
- 4.4. Surgical ENT Devices
- 4.4.1. Surgical ENT devices market, 2018 - 2030 (USD Million)
- 4.4.2. Radiofrequency handpieces
- 4.4.2.1. Radiofrequency handpieces market, 2018 - 2030 (USD Million)
- 4.4.3. Otological drill burrs
- 4.4.3.1. Otological drill burrs market, 2018 - 2030 (USD Million)
- 4.4.4. ENT hand instruments
- 4.4.4.1. ENT hand instruments market, 2018 - 2030 (USD Million)
- 4.4.5. Sinus dilation devices
- 4.4.5.1. Sinus dilation devices market, 2018 - 2030 (USD Million)
- 4.4.6. Nasal packing devices
- 4.4.6.1. Nasal packing devices market, 2018 - 2030 (USD Million)
- 4.4.7. Others
- 4.4.7.1. Others market, 2018 - 2030 (USD Million)
- 4.5. Diagnostic ENT Devices
- 4.5.1. Diagnostic ENT devices market, 2018 - 2030 (USD Million)
- 4.6. Hearing aids
- 4.6.1. Hearing aids market, 2018 - 2030 (USD Million)
- 4.7. Hearing Implants
- 4.7.1. Hearing implants market, 2018 - 2030 (USD Million)
- 4.8. Nasal Splints
- 4.8.1. Nasal splints market, 2018 - 2030 (USD Million)
Chapter 5. Region, By Treatment, 2018 - 2030 (USD Million)
- 5.1. Regional Market Dashboard
- 5.2. Regional marketplace: Key takeaways
- 5.3. North America
- 5.3.1. North America ENT devices market estimates and forecast, 2018 - 2030 (USD million)
- 5.3.2. U.S.
- 5.3.2.1. Key country dynamics
- 5.3.2.2. U.S. estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.3.2.3. Regulatory scenario
- 5.3.2.4. Reimbursement scenario
- 5.3.2.5. Competitive insights
- 5.3.2.6. U.S. ENT devices market, 2018 - 2030 (USD Million)
- 5.3.3. Canada
- 5.3.3.1. Key country dynamics
- 5.3.3.2. Canada estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.3.3.3. Regulatory scenario
- 5.3.3.4. Reimbursement scenario
- 5.3.3.5. Competitive insights
- 5.3.3.6. Canada ENT devices market, 2018 - 2030 (USD Million)
- 5.3.4. Mexico
- 5.3.4.1. Key country dynamics
- 5.3.4.2. Mexico estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.3.4.3. Regulatory scenario
- 5.3.4.4. Reimbursement scenario
- 5.3.4.5. Competitive insights
- 5.3.4.6. Mexico ENT devices market, 2018 - 2030 (USD Million)
- 5.4. Europe
- 5.4.1. Europe ENT devices market estimates and forecast, 2018 - 2030 (USD million)
- 5.4.2. UK
- 5.4.2.1. Key country dynamics
- 5.4.2.2. UK estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.2.3. Regulatory scenario
- 5.4.2.4. Reimbursement scenario
- 5.4.2.5. Competitive insights
- 5.4.2.6. UK ENT devices market, 2018 - 2030 (USD Million)
- 5.4.3. Germany
- 5.4.3.1. Key country dynamics
- 5.4.3.2. Germany estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.3.3. Regulatory scenario
- 5.4.3.4. Reimbursement scenario
- 5.4.3.5. Competitive insights
- 5.4.3.6. Germany ENT devices market, 2018 - 2030 (USD Million)
- 5.4.4. France
- 5.4.4.1. Key country dynamics
- 5.4.4.2. France estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.4.3. Regulatory scenario
- 5.4.4.4. Reimbursement scenario
- 5.4.4.5. Competitive insights
- 5.4.4.6. France ENT devices market, 2018 - 2030 (USD Million)
- 5.4.5. Italy
- 5.4.5.1. Key country dynamics
- 5.4.5.2. Italy estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.5.3. Regulatory scenario
- 5.4.5.4. Reimbursement scenario
- 5.4.5.5. Competitive insights
- 5.4.5.6. Italy ENT devices market, 2018 - 2030 (USD Million)
- 5.4.6. Spain
- 5.4.6.1. Key country dynamics
- 5.4.6.2. Spain estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.6.3. Regulatory scenario
- 5.4.6.4. Reimbursement scenario
- 5.4.6.5. Competitive insights
- 5.4.6.6. Spain ENT devices market, 2018 - 2030 (USD Million)
- 5.4.7. Norway
- 5.4.7.1. Key country dynamics
- 5.4.7.2. Norway estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.7.3. Regulatory scenario
- 5.4.7.4. Reimbursement scenario
- 5.4.7.5. Competitive insights
- 5.4.7.6. Norway ENT devices market, 2018 - 2030 (USD Million)
- 5.4.8. Sweden
- 5.4.8.1. Key country dynamics
- 5.4.8.2. Sweden estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.8.3. Regulatory scenario
- 5.4.8.4. Reimbursement scenario
- 5.4.8.5. Competitive insights
- 5.4.8.6. Sweden ENT devices market, 2018 - 2030 (USD Million)
- 5.4.9. Denmark
- 5.4.9.1. Key country dynamics
- 5.4.9.2. Denmark estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.4.9.3. Regulatory scenario
- 5.4.9.4. Reimbursement scenario
- 5.4.9.5. Competitive insights
- 5.4.9.6. Denmark ENT devices market, 2018 - 2030 (USD Million)
- 5.5. Asia Pacific
- 5.5.1. Asia Pacific ENT devices market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5.2. Japan
- 5.5.2.1. Key country dynamics
- 5.5.2.2. Japan estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.2.3. Regulatory scenario
- 5.5.2.4. Reimbursement scenario
- 5.5.2.5. Competitive insights
- 5.5.2.6. Japan ENT devices market, 2018 - 2030 (USD Million)
- 5.5.3. China
- 5.5.3.1. Key country dynamics
- 5.5.3.2. China estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.3.3. Regulatory scenario
- 5.5.3.4. Reimbursement scenario
- 5.5.3.5. Competitive insights
- 5.5.3.6. China ENT devices market, 2018 - 2030 (USD Million)
- 5.5.4. India
- 5.5.4.1. Key country dynamics
- 5.5.4.2. India estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.4.3. Regulatory scenario
- 5.5.4.4. Reimbursement scenario
- 5.5.4.5. Competitive insights
- 5.5.4.6. India ENT devices market, 2018 - 2030 (USD Million)
- 5.5.5. Australia
- 5.5.5.1. Key country dynamics
- 5.5.5.2. Australia estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.5.3. Regulatory scenario
- 5.5.5.4. Reimbursement scenario
- 5.5.5.5. Competitive insights
- 5.5.5.6. Australia ENT devices market, 2018 - 2030 (USD Million)
- 5.5.6. South Korea
- 5.5.6.1. Key country dynamics
- 5.5.6.2. South Korea estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.6.3. Regulatory scenario
- 5.5.6.4. Reimbursement scenario
- 5.5.6.5. Competitive insights
- 5.5.6.6. South Korea ENT devices market, 2018 - 2030 (USD Million)
- 5.5.7. Thailand
- 5.5.7.1. Key country dynamics
- 5.5.7.2. Thailand estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.5.7.3. Regulatory scenario
- 5.5.7.4. Reimbursement scenario
- 5.5.7.5. Competitive insights
- 5.5.7.6. Thailand ENT devices market, 2018 - 2030 (USD Million)
- 5.6. Latin America
- 5.6.1. Latin America ENT devices market estimates and forecast, 2018 - 2030 (USD million)
- 5.6.2. Brazil
- 5.6.2.1. Key country dynamics
- 5.6.2.2. Brazil estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.6.2.3. Regulatory scenario
- 5.6.2.4. Reimbursement scenario
- 5.6.2.5. Competitive insights
- 5.6.2.6. Brazil ENT devices market, 2018 - 2030 (USD Million)
- 5.6.3. Argentina
- 5.6.3.1. Key country dynamics
- 5.6.3.2. Argentina estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.6.3.3. Regulatory scenario
- 5.6.3.4. Reimbursement scenario
- 5.6.3.5. Competitive insights
- 5.6.3.6. Argentina ENT devices market, 2018 - 2030 (USD Million)
- 5.7. MEA
- 5.7.1. MEA ENT devices market estimates and forecast, 2018 - 2030 (USD million)
- 5.7.2. South Africa
- 5.7.2.1. Key country dynamics
- 5.7.2.2. South Africa estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.7.2.3. Regulatory scenario
- 5.7.2.4. Reimbursement scenario
- 5.7.2.5. Competitive insights
- 5.7.2.6. South Africa ENT devices market, 2018 - 2030 (USD Million)
- 5.7.3. Saudi Arabia
- 5.7.3.1. Key country dynamics
- 5.7.3.2. Saudi Arabia estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.7.3.3. Regulatory scenario
- 5.7.3.4. Reimbursement scenario
- 5.7.3.5. Competitive insights
- 5.7.3.6. Saudi Arabia ENT devices market, 2018 - 2030 (USD Million)
- 5.7.4. UAE
- 5.7.4.1. Key country dynamics
- 5.7.4.2. UAE estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.7.4.3. Regulatory scenario
- 5.7.4.4. Reimbursement scenario
- 5.7.4.5. Competitive insights
- 5.7.4.6. UAE ENT devices market, 2018 - 2030 (USD Million)
- 5.7.5. Kuwait
- 5.7.5.1. Key country dynamics
- 5.7.5.2. Kuwait estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
- 5.7.5.3. Regulatory scenario
- 5.7.5.4. Reimbursement scenario
- 5.7.5.5. Competitive insights
- 5.7.5.6. Kuwait ENT devices market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company Categorization
- 6.3. Company Market Position Analysis
- 6.4. Company Profiles
- 6.4.1. Ambu A/S
- 6.4.1.1. Company overview
- 6.4.1.2. Financial performance
- 6.4.1.3. Product benchmarking
- 6.4.1.4. Strategic initiatives
- 6.4.2. Cochlear Ltd.
- 6.4.2.1. Company overview
- 6.4.2.2. Financial performance
- 6.4.2.3. Product benchmarking
- 6.4.2.4. Strategic initiatives
- 6.4.3. Demant A/S
- 6.4.3.1. Company overview
- 6.4.3.2. Financial performance
- 6.4.3.3. Product benchmarking
- 6.4.3.4. Strategic initiatives
- 6.4.4. Sonova
- 6.4.4.1. Company overview
- 6.4.4.2. Financial performance
- 6.4.4.3. Product benchmarking
- 6.4.4.4. Strategic initiatives
- 6.4.5. GN Store Nord A/S
- 6.4.5.1. Company overview
- 6.4.5.2. Financial performance
- 6.4.5.3. Product benchmarking
- 6.4.5.4. Strategic initiatives
- 6.4.6. Karl Storz
- 6.4.6.1. Company overview
- 6.4.6.2. Financial performance
- 6.4.6.3. Product benchmarking
- 6.4.6.4. Strategic initiatives
- 6.4.7. Olympus Corporation
- 6.4.7.1. Company overview
- 6.4.7.2. Financial performance
- 6.4.7.3. Product benchmarking
- 6.4.7.4. Strategic initiatives
- 6.4.8. PENTAX Medical
- 6.4.8.1. Company overview
- 6.4.8.2. Financial performance
- 6.4.8.3. Product benchmarking
- 6.4.8.4. Strategic initiatives
- 6.4.9. Richard Wolf GmbH
- 6.4.9.1. Company overview
- 6.4.9.2. Financial performance
- 6.4.9.3. Product benchmarking
- 6.4.9.4. Strategic initiatives
- 6.4.10. Rion Co., Ltd.
- 6.4.10.1. Company overview
- 6.4.10.2. Financial performance
- 6.4.10.3. Product benchmarking
- 6.4.10.4. Strategic initiatives
- 6.4.11. Smith & Nephew plc
- 6.4.11.1. Company overview
- 6.4.11.2. Financial performance
- 6.4.11.3. Product benchmarking
- 6.4.11.4. Strategic initiatives
- 6.4.12. Starkey Laboratories, Inc.
- 6.4.12.1. Company overview
- 6.4.12.2. Financial performance
- 6.4.12.3. Product benchmarking
- 6.4.12.4. Strategic initiatives
- 6.4.13. Stryker
- 6.4.13.1. Company overview
- 6.4.13.2. Financial performance
- 6.4.13.3. Product benchmarking
- 6.4.13.4. Strategic initiatives
- 6.4.14. MED-EL Medical Electronics
- 6.4.14.1. Company overview
- 6.4.14.2. Financial performance
- 6.4.14.3. Product benchmarking
- 6.4.14.4. Strategic initiatives
- 6.4.15. Nemera
- 6.4.15.1. Company overview
- 6.4.15.2. Financial performance
- 6.4.15.3. Product benchmarking
- 6.4.15.4. Strategic initiatives